Alaska Chapter of the American College of Cardiology

CKM Syndrome: Insights From and Comparison of Recent Guidelines
The 2026 ACC/AHA/Multisociety Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome provides an expanded framework for assessing and managing interconnected metabolic risk factors...
FDA Update: Agency Warns of Transcatheter MV Delivery System Issue
The U.S. Food and Drug Administration (FDA) has issued an Early Alert, warning that Edwards Lifesciences is recommending certain delivery systems used for the SAPIEN M3 transcatheter mitral valve (MV) replacement be removed from use.
Pullback Pressure Gradient: Unlocking the Functional Map of CAD
Coronary angiography has long served as the anatomical cornerstone for guiding PCI. Yet, the visual severity of a stenosis does not always reflect its physiological significance.
Interventional Post-ACS Antithrombotic Trials at ESC Congress 2026
Four late-breaking trials, presented at ESC Congress 2026 focused on post-acute coronary syndrome (ACS) antithrombotic therapy.
Sports Cardiology Research and Guideline Highlights: Early 2026
The 2026 ESC/ACC clinical consensus statement on Masters Athletes With Abnormal Cardiovascular Findings is guided by a clinical consensus statement outlining expert recommendations for the diagnostic assessment, management, and risk stratification of cardiac abnormalities in masters athletes (MAs).